Playing by the rules
A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functio...
Gespeichert in:
Veröffentlicht in: | Nutraceutical Business & Technology 2012-03, Vol.8 (2), p.16 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | 16 |
container_title | Nutraceutical Business & Technology |
container_volume | 8 |
creator | Ranson, Paul Eggers, Melanie |
description | A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's... |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_reports_1024813579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A283869223</galeid><sourcerecordid>A283869223</sourcerecordid><originalsourceid>FETCH-LOGICAL-g929-42d7776e71c54d6258084e0131d62d4280c0161737674f0b6c3c780672ee9113</originalsourceid><addsrcrecordid>eNpNzE1Lw0AQBuA9KFhqb_6AoFcDO_s1m2MpfkFBQe8h2UzSSEzqTnLov3ehHjqH9-WFh7kSK0Bjc68l3ogN87dMZ0E7hStx9zFUp37ssvqUzQfK4jIQ34rrthqYNv-9Fp_PT1-713z__vK22-7zrlBFblSDiI4QgjWNU9ZLb0iChjQao7wMEhygRoemlbULOqCXDhVRAaDX4v789Rin34V4LiMdpzhzCVIZD9pikdDDGXXVQGU_ttMcq_DTcyi3ymvvCqV0Uo8Xql64H4lTcN8dZu6qhfmS_wFixEwu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024813579</pqid></control><display><type>article</type><title>Playing by the rules</title><source>Business Source Complete</source><creator>Ranson, Paul ; Eggers, Melanie</creator><creatorcontrib>Ranson, Paul ; Eggers, Melanie</creatorcontrib><description>A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...</description><identifier>ISSN: 1745-8307</identifier><language>eng</language><publisher>Leatherhead: Via Communications Ltd (formerly Via Media Ltd)</publisher><subject>Compliance ; Dietary minerals ; Dietary supplements ; EU directives ; FDA approval ; Food ; Food industry ; Labeling ; Laws, regulations and rules ; Legislation ; Manufacturers ; Nutrition ; Pharmaceutical industry ; Physiology ; Regulation ; Vitamins</subject><ispartof>Nutraceutical Business & Technology, 2012-03, Vol.8 (2), p.16</ispartof><rights>COPYRIGHT 2012 Via Communications Ltd (formerly Via Media Ltd)</rights><rights>Copyright Via Media UK Ltd. Mar/Apr 2012</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,314,776,780,787</link.rule.ids></links><search><creatorcontrib>Ranson, Paul</creatorcontrib><creatorcontrib>Eggers, Melanie</creatorcontrib><title>Playing by the rules</title><title>Nutraceutical Business & Technology</title><description>A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...</description><subject>Compliance</subject><subject>Dietary minerals</subject><subject>Dietary supplements</subject><subject>EU directives</subject><subject>FDA approval</subject><subject>Food</subject><subject>Food industry</subject><subject>Labeling</subject><subject>Laws, regulations and rules</subject><subject>Legislation</subject><subject>Manufacturers</subject><subject>Nutrition</subject><subject>Pharmaceutical industry</subject><subject>Physiology</subject><subject>Regulation</subject><subject>Vitamins</subject><issn>1745-8307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>N95</sourceid><sourceid>BENPR</sourceid><recordid>eNpNzE1Lw0AQBuA9KFhqb_6AoFcDO_s1m2MpfkFBQe8h2UzSSEzqTnLov3ehHjqH9-WFh7kSK0Bjc68l3ogN87dMZ0E7hStx9zFUp37ssvqUzQfK4jIQ34rrthqYNv-9Fp_PT1-713z__vK22-7zrlBFblSDiI4QgjWNU9ZLb0iChjQao7wMEhygRoemlbULOqCXDhVRAaDX4v789Rin34V4LiMdpzhzCVIZD9pikdDDGXXVQGU_ttMcq_DTcyi3ymvvCqV0Uo8Xql64H4lTcN8dZu6qhfmS_wFixEwu</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Ranson, Paul</creator><creator>Eggers, Melanie</creator><general>Via Communications Ltd (formerly Via Media Ltd)</general><general>Via Media UK Ltd</general><scope>N95</scope><scope>XI7</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>4T-</scope><scope>7WY</scope><scope>7XB</scope><scope>883</scope><scope>88A</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>LK8</scope><scope>M0F</scope><scope>M7P</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYYUZ</scope><scope>Q9U</scope></search><sort><creationdate>20120301</creationdate><title>Playing by the rules</title><author>Ranson, Paul ; Eggers, Melanie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g929-42d7776e71c54d6258084e0131d62d4280c0161737674f0b6c3c780672ee9113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Compliance</topic><topic>Dietary minerals</topic><topic>Dietary supplements</topic><topic>EU directives</topic><topic>FDA approval</topic><topic>Food</topic><topic>Food industry</topic><topic>Labeling</topic><topic>Laws, regulations and rules</topic><topic>Legislation</topic><topic>Manufacturers</topic><topic>Nutrition</topic><topic>Pharmaceutical industry</topic><topic>Physiology</topic><topic>Regulation</topic><topic>Vitamins</topic><toplevel>online_resources</toplevel><creatorcontrib>Ranson, Paul</creatorcontrib><creatorcontrib>Eggers, Melanie</creatorcontrib><collection>Gale Business: Insights</collection><collection>Business Insights: Essentials</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>ABI/INFORM Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade & Industry (Alumni Edition)</collection><collection>Biology Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Trade & Industry</collection><collection>Biological Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><jtitle>Nutraceutical Business & Technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranson, Paul</au><au>Eggers, Melanie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Playing by the rules</atitle><jtitle>Nutraceutical Business & Technology</jtitle><date>2012-03-01</date><risdate>2012</risdate><volume>8</volume><issue>2</issue><spage>16</spage><pages>16-</pages><issn>1745-8307</issn><abstract>A medicinal product is defined in Directive 2001 /83/EC (the principle EU medicinal legislation) as a substance that is "presented for treating or preventing or "may be administered ... with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions."1 The first aspect of the definition - being a medicinal product by presentation - takes into any implicit or explicit claims made in relation to a medicine and the general impression given by the product's...</abstract><cop>Leatherhead</cop><pub>Via Communications Ltd (formerly Via Media Ltd)</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1745-8307 |
ispartof | Nutraceutical Business & Technology, 2012-03, Vol.8 (2), p.16 |
issn | 1745-8307 |
language | eng |
recordid | cdi_proquest_reports_1024813579 |
source | Business Source Complete |
subjects | Compliance Dietary minerals Dietary supplements EU directives FDA approval Food Food industry Labeling Laws, regulations and rules Legislation Manufacturers Nutrition Pharmaceutical industry Physiology Regulation Vitamins |
title | Playing by the rules |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T05%3A12%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Playing%20by%20the%20rules&rft.jtitle=Nutraceutical%20Business%20&%20Technology&rft.au=Ranson,%20Paul&rft.date=2012-03-01&rft.volume=8&rft.issue=2&rft.spage=16&rft.pages=16-&rft.issn=1745-8307&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA283869223%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1024813579&rft_id=info:pmid/&rft_galeid=A283869223&rfr_iscdi=true |